Cargando…
Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments
Antibiotic combination therapy is used for severe infections caused by multidrug-resistant (MDR) Gram-negative bacteria, yet data regarding which combinations are most effective are lacking. This study aimed to evaluate the in vitro efficacy of polymyxin B in combination with 13 other antibiotics ag...
Autores principales: | Olsson, Anna, Wistrand-Yuen, Pikkei, Nielsen, Elisabet I., Friberg, Lena E., Sandegren, Linus, Lagerbäck, Pernilla, Tängdén, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269485/ https://www.ncbi.nlm.nih.gov/pubmed/32179531 http://dx.doi.org/10.1128/AAC.02111-19 |
Ejemplares similares
-
Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48- and NDM-Producing Escherichia coli and Klebsiella pneumoniae
por: Allander, Lisa, et al.
Publicado: (2022) -
A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures
por: Malmberg, Christer, et al.
Publicado: (2016) -
Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases
por: Olsson, Anna, et al.
Publicado: (2021) -
A Multiplex Fluidic Chip for Rapid Phenotypic Antibiotic Susceptibility Testing
por: Wistrand-Yuen, Pikkei, et al.
Publicado: (2020) -
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program
por: Satlin, Michael J., et al.
Publicado: (2023)